514 filings
Page 6 of 26
8-K
9qiew
5 Mar 18
ArQule Reports Fourth Quarter and Full Year 2017 Financial Results
12:00am
8-K
tpzfip6jpfbum4oz4 7c
22 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
12w3us tvqnrz9tp1q
7 Feb 18
Roivant Sciences and ArQule Enter into License Agreement for Derazantinib in China
12:00am
EFFECT
uls soguvnbv3c
19 Dec 17
Notice of effectiveness
12:00am
CT ORDER
yktxdkld 2tcqim
12 Dec 17
Confidential treatment order
12:00am
8-K
m84l q9ssu
9 Nov 17
ArQule Reports Third Quarter 2017 Financial Results
12:00am
8-K
nm7m4zw57q5ehm0
8 Nov 17
ArQule Announces $9.5 Million Private Placement of Preferred Stock
12:00am
8-K
hvkyhw5eiin35ut1 oxq
16 Oct 17
ArQule Announces $15.7 Million Private Placement of Common Stock
12:00am
8-K
n6ga9 21kd4yyb5pkrk5
29 Sep 17
Notice of Ratification of Potentially Defective Corporate Acts
12:00am
8-K
ss8fw0nct z4d
4 Aug 17
ArQule Reports Second Quarter 2017 Financial Results
12:00am
8-K
yzsi 7l3ch
26 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
dk0 kma8an0vtx7
24 May 17
Report of Matters Voted Upon by Stockholders
12:00am
8-K
wlboj0 l8
3 May 17
Arqule Reports First Quarter 2017 Financial Results
12:00am